Story · Medicine & Biotech

Georgina Long: INTerpath-001 mRNA Vaccine Improves Recurrence-Free Survival in High-Risk Melanoma

1 outlet · first reported by OncoDaily on

Georgina Long, Medical Director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research at the University of Sydney, shared on X: “I am delighted to share (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Georgina Long: INTerpath-001 mRNA Vaccine Improves Recurrence-Free Survival in High-Risk Melanoma

    Georgina Long, Medical Director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research at the University of Sydney, shared on X: “I am delighted to share

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.